The use of dobutamine stress echocardiography for the determination of myocardial viability

Clinical Cardiology

Volumn 19, Issue 8, 1996, Pages 607-612

  Hansen, Todd H ^a   Segar, Douglas S ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

dobutamine stress echocardiography; hibernating myocardium; stunned myocardium

Indexed keywords

DOBUTAMINE;

ACUTE HEART INFARCTION; CELL VIABILITY; CHRONOTROPISM; CLINICAL TRIAL; DIAGNOSTIC VALUE; EXERCISE ELECTROCARDIOGRAPHY; HUMAN; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; REVIEW; STUNNED HEART MUSCLE;

EID: 0029832457     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960190806     Document Type: Review

References (22)

1. Rahimtoola SH: The hibernating myocardium. Am Heart J 1989; 117:211-221
2. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M: Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-795
3. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, MacIntyre WI, Thomas JD: Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-2694
4. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H: Reversibility of cardiac wall motion abnormalities by positron emission tomography. N Engl J Med 1986; 314:884-888
5. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO: Enhanced detection of ischemic but viable myocardium by reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-146
6. Van Vlies B, Baas J, Visser CA, van Royen EA, Delemarre BJ, Bot G, Dunning AJ: Early indium-111 antimyosin scintigraphy for assessment of regional wall motion asynergy on discharge after myocardial infarction. Int J Card Imaging 1990;5:241-248
7. Takeda K, LaFrance ND, Weisman HF, Wagner HN, Becker LC: Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction. J Am Coll Cardiol 1991;17:519-526
8. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R, Fineberg NS, Armstrong WF, Feigenbaum H: Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991;83:1605-1614
9. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, Feigenbaum H: Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography, experience in 1118 patients. Circulation 1993;88:15-19
10. Loeb H, Khan M, Klodnycky M, Sinno MZ, Towne ND, Gunar RM: Hemodynamic effects of dobutamine in man. Circ Shock 1975;2:29-35
11. Meyer SL, Curry GC, Donsky MS, Twieg DB, Parkey RW, Willerson JT: Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol 1976;38:103-108
12. Mercier JC, Lando U, Kanmatsuse K, Ninomiya K, Meerbaum S, Fishbein MC, Swan HJC, Ganz W: Divergent effects of inotropic stimulation of the ischemic and severely depressed reperfused myocardium. Circulation 1982;66:397-400
13. Pierard LA, De Landsheere CN, Berthe C, Rigo P, Kulbertus H: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-1031
14. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S: Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-1531
15. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K, Bourdillon PDV, Feigenbaum H: Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-415
16. Watada H, Ito H, Oh H, Masuyama T, Aburaya M, Hori M, Iwakura M, Higashino Y, Fujii K, Minamino T: Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994;24:624-630
17. Salustri A, Ekhendy A, Garyfallydis P, Ciavatti M, Cornel JH, ten Cate FJ, Boersma E, Gemelli A, Roelandt JRTC, Fioretti PM: Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol 1994;74:853-856
18. Marzullo P, Parodi O, Reisenhofer B, Sambuceti G, Picano E, Distante A, Gimellim A, L'Abbate A: Value of rest thallium-201/ technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-172
19. Cigarroa CG, deFilippi CR, Brickner E, Alvarez LG, Wait MA, Grayburn PA: Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88: 430-436
20. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O: Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-626
21. Chamey R, Schwinger ME, Chun J, Cohen MV, Nanna M, Menegus MA, Wexler J, Spindola Franco H, Greenberg MA: Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 1994;128:864-869
22. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA: Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-670